TABLE OF CONTENTS

 

 

1.     Overview and Agenda

 

2.     Topical Steroid Potency Ranking

 

3.     Drug Labels for Topical Corticosteroids

 

4.     Drug Labels and FDA Approval Letters for Calcineurin Inhibitors

 

5.     Post-marketing Safety Reviews

 

6.     Journal Articles

 

7.     Drug Labels for BPCA Adverse Event Reports